Skip to content

Construction and application of intelligent follow-up cloud platform for ischemic stroke

Construction and application of intelligent follow-up cloud platform for ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080256
Enrollment
Unknown
Registered
2024-01-24
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral vascular disease

Interventions

experimental group:Wechat mini-program management
control group:traditional telephone management

Sponsors

Yao Zhu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: First-time stroke (ischemic). Age between 18 to 85 years old. Modified Rankin Scale (mRS) score =4 (mild to moderate disability). At least one vascular risk factor that requires medical intervention, including: hypertension, hyperlipidemia, smoking, alcohol abuse, diabetes, lack of exercise, poor mood, overweight, and genetic factors, etc. Consent to participate in the study and follow up, including stroke survivors and caregivers. Having a designated caregiver at home who is responsible for follow-up and care, and has an internet-accessible computer, smartphone, or other smart device (iOS or Android platform). The stroke is medically stable, and the participant can return to normal community life after discharge from the hospital (thus excluding patients related to valve removal surgery, carotid artery endarterectomy, and hospital-acquired sepsis treatment). The patient himself or his legal representative signs the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Severe aphasia, visual neglect, short-term memory loss, dementia. Iatrogenic stroke, that is, caused by non-atherosclerotic vascular diseases and rare causes, such as carotid artery dissection, coronary artery bypass surgery. Stroke patients/caregivers who continue post-stroke rehabilitation in professional care institutions or hospital environments and do not return to the community after discharge. Serious comorbidities, such as cancer, kidney failure, mental disorders, that affect disease assessment, exclude patients requiring stroke prevention drugs or non-standardized treatment. Any use of drugs beyond the instructions, non-guided use of drugs. Pregnant or lactating women. Expected lifespan <1 year. Currently participating in other clinical trials. Patients who cannot complete a 90-day follow-up (such as those without a fixed address, overseas patients, etc).

Design outcomes

Primary

MeasureTime frame
sttoke mortality ;stroke recurrence rate;Rehospitalization rate;

Secondary

MeasureTime frame
Control of risk factors (blood pressure, blood lipids, smoking, alcohol abuse, diabetes, exercise, mood, BMI, and genetic factors, etc.);Disease awareness rate;Follow-up man-hours and cost;

Countries

China

Contacts

Public ContactYao Zhu

The First Affiliated Hospital of university of Science and Technology of China

ustcyaozhu@ustc.edu.cn+86 180 0963 1316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026